TrialHuman vaccines & immunotherapeutics2026

Optimized seasonal influenza mRNA vaccine compositions demonstrate safety and enhanced immunogenicity in a phase 2 study.

Carlos Fierro et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.